Erratum: Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor

Toby A. Eyre; Yuqin Song; Olivier Hermine; Yuerong Shuang; Wojciech Jurczak; Joao Samuel Farias; Carolina Mahuad; Muhit Ozcan; Ron D. Jachimowicz; Tianlei Chen; Elena Ivanova; Xiaotong Li; Gabriel Man; Priscille Bourquelot; Remus Vezan; Michael Wang

doi:10.1200/jco-26-01699

Erratum: Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor

T Toby A. Eyre (8Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom) Y Yuqin Song O Olivier Hermine Y Yuerong Shuang W Wojciech Jurczak J Joao Samuel Farias (Liga Paranaense de Combate ao Câncer, Curitiba, Paraná, Brazil) C Carolina Mahuad M Muhit Ozcan (14Ankara University School of Medicine, Ankara, Türkiye) R Ron D. Jachimowicz T Tianlei Chen (20BeOne Medicines Ltd, San Carlos, United States) E Elena Ivanova X Xiaotong Li (Department of Chemistry and Organic and Carbon Electronics Laboratories (ORaCEL)) G Gabriel Man (15BeOne Medicines Ltd, San Carlos, United States) P Priscille Bourquelot (10BeOne Medicines Ltd, San Carlos, United States) R Remus Vezan (18BeOne Medicines Ltd, San Carlos, United States) M Michael Wang

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Journal of Clinical Oncology

Volume / Issue Vol. 44, Issue 23

Published August 10, 2026

Pages 2258-2258

DOI 10.1200/jco-26-01699

ISSN 0732-183X

Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (16)

T

Toby A. Eyre

8Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom

Y

Yuqin Song

O

Olivier Hermine

Y

Yuerong Shuang

W

Wojciech Jurczak

J

Joao Samuel Farias

Liga Paranaense de Combate ao Câncer, Curitiba, Paraná, Brazil

C

Carolina Mahuad

M

Muhit Ozcan

14Ankara University School of Medicine, Ankara, Türkiye

R

Ron D. Jachimowicz

T

Tianlei Chen

20BeOne Medicines Ltd, San Carlos, United States

E

Elena Ivanova

X

Xiaotong Li

Department of Chemistry and Organic and Carbon Electronics Laboratories (ORaCEL)

G

Gabriel Man

15BeOne Medicines Ltd, San Carlos, United States

P

Priscille Bourquelot

10BeOne Medicines Ltd, San Carlos, United States

R

Remus Vezan

18BeOne Medicines Ltd, San Carlos, United States

M

Michael Wang

Erratum: Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor

Article Details

Journal Info

Authors (16)

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer